A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Hosp Univ Fund Jimenez Diaz, Madrid

Clinica Univ. de Navarra, Pamplona

Florida Specialist and Cancer Institute, Sarasota

Carmel Medical Center, Haifa

Hosp Clinico Univ de Salamanca, Salamanca

Universitaetsklinikum Duesseldorf, Düsseldorf

Hosp. Virgen Del Rocio, Seville

Ohio State University, Columbus

Goethe Universität Frankfurt, Frankfurt am Main

University of Texas, MD Anderson Cancer Center, Houston

Tel Aviv Sourasky MC, Tel Aviv

Hadassah Medical Center, Jerusalem

Massachusetts General Hospital, Boston

St. Paul's Hospital, Vancouver

Princess Margaret Cancer Centre University Health Network, Toronto

Universitaetsklinikum Leipzig, Leipzig

Hosp. Univ. Germans Trias I Pujol, Badalona

Hosp Univ Vall D Hebron, Barcelona